申请人:Yao Wenqing
公开号:US20060004049A1
公开(公告)日:2006-01-05
The present invention relates to inhibitors of 11-β hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-β hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
本发明涉及11-β羟基类固醇脱氢酶类型1的抑制剂、矿物皮质激素受体(MR)的拮抗剂以及其药物组合物。本发明的化合物可用于治疗与11-β羟基类固醇脱氢酶类型1的表达或活性有关的各种疾病,以及与醛固酮过量有关的疾病。